Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
828.40    3.20 (0.39%)
Bid:
827.60
Ask:
828.40
Spread: 0.80 (0.097%)
Market Cap: £7.46b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

Stabilisation Notice

1 Feb 2022 10:26

RNS Number : 3215A
J.P. Morgan Securities PLC.
01 February 2022
 

1st of February 2022

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

The Sage Group plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Marc Lewell +33 1 40 15 44 39) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

The Sage Group plc

Guarantor (if any):

Sage Treasury Company Limited

Aggregate nominal amount:

GBP bmk

Description:

GBP 12-year Senior, Unsecured, RegS Bearer, NGN, TEFRA D rules apply (no communications with or into the U.S.)

Listing: London Stock Exchange

Offer price:

TBD

Other offer terms:

Denoms: £100k + 1k

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

NatWest Markets (Stabilisation Manager(s))

HSBC ( (Stabilisation Manager(s))

BofA ( (Stabilisation Manager(s))

 

Stabilisation period expected to start on:

1st February 2022

Stabilisation period expected to end no later than:

1st March 2022

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAEAFEAAAEFA
Date   Source Headline
9th Mar 202010:06 amRNSDirector/PDMR Shareholding
6th Mar 20205:55 pmRNSDirector/PDMR Shareholding
6th Mar 20205:50 pmRNSDirector/PDMR Shareholding
2nd Mar 20207:00 amRNSDisposal of Brazilian business
28th Feb 20205:08 pmRNSTotal Voting Rights
25th Feb 20203:35 pmRNSDirectorate Change
25th Feb 20203:29 pmRNSResult of AGM
6th Feb 20203:16 pmRNSDirector Declaration
31st Jan 20205:12 pmRNSTotal Voting Rights
23rd Jan 20204:00 pmRNSNotice of AGM
22nd Jan 20203:57 pmRNSDirector Declaration
22nd Jan 20207:00 amRNSTrading Update
17th Jan 20207:00 amRNSDirectorate Change
17th Jan 20207:00 amRNSDirectorate Change
16th Jan 20203:30 pmRNSHolding(s) in Company
14th Jan 20204:19 pmRNSHolding(s) in Company
31st Dec 201912:57 pmRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector/PDMR Shareholding
17th Dec 20192:05 pmRNSDirector/PDMR Shareholding
16th Dec 201911:36 amRNSDirector/PDMR Shareholding
10th Dec 20193:44 pmRNSDirector/PDMR Shareholding
6th Dec 20194:31 pmRNSBlock listing Interim Review
5th Dec 20194:56 pmRNSDirector/PDMR Shareholding
4th Dec 20191:35 pmRNSAnnual Financial Report
3rd Dec 20192:52 pmRNSDirector/PDMR Shareholding
29th Nov 20194:10 pmRNSTotal Voting Rights
26th Nov 20193:01 pmRNSDirector/PDMR Shareholding
20th Nov 20194:43 pmRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSThe Sage Group plc audited results for FY19
18th Nov 20197:00 amRNSDisposal of Sage Pay
5th Nov 20194:57 pmRNSHolding(s) in Company
31st Oct 20194:48 pmRNSTotal Voting Rights
10th Oct 20195:38 pmRNSDirector Declaration
30th Sep 20196:27 pmRNSTotal Voting Rights
23rd Sep 20194:14 pmRNSDirector/PDMR Shareholding
16th Sep 201911:01 amRNSDirector/PDMR Shareholding
9th Sep 20196:27 pmRNSThe Sage Group plc Statement re. Press Comment
9th Sep 20195:03 pmRNSDirector/PDMR Shareholding
30th Aug 20194:43 pmRNSTotal Voting Rights
15th Aug 20194:56 pmRNSDirector/PDMR Shareholding
13th Aug 20195:44 pmRNSDirector/PDMR Shareholding
13th Aug 20195:24 pmRNSDirector/PDMR Shareholding
6th Aug 20196:00 pmRNSDirector/PDMR Shareholding
1st Aug 20194:15 pmRNSDirector/PDMR Shareholding
31st Jul 20194:45 pmRNSTotal Voting Rights
25th Jul 20197:00 amRNSTrading Update
18th Jul 20192:53 pmRNSDirector Declaration
28th Jun 20194:08 pmRNSTotal Voting Rights
26th Jun 20194:09 pmRNSDirector/PDMR Shareholding
17th Jun 20195:38 pmRNSGrant of Options under Sage Save & Share Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.